Skip to main content

Table 3 Time on unique medications within the CPRD Migraine Preventive Treatment User Cohort (N = 34,448)

From: Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years

Medication

N (with at least one prescription)

Median time on treatment (days)*

Mean time on treatment (days (SD))*

Amitriptyline

13,752

56

267 (438)

Atenolol

1133

161

490 (629)

Bisoprolol fumarate

1326

168.5

424 (551)

Candesartan cilexetil

714

134

363 (512)

Flunarizine

14

58

155 (254)

Gabapentin

4169

106

301 (432)

Metoprolol tartrate

173

121

428 (630)

Nadolol

18

187.5

316 (344)

Nortriptyline

1485

94

253 (390)

Pizotifen

4623

64

246 (400)

Propranolol hydrochloride

13,087

62

262 (423)

Sodium valproate/valproic acid

617

161

413 (546)

Timolol maleate

104

379

641 (696)

Topiramate

2555

154

345 (438)

Verapamil

314

87

327 (476)

  1. CPRD: Clinical Practice Research Datalink; N: number of patients in total population
  2. *Time on treatment was assessed during the preventive medication/medication class assessment period